Qiuping Lu - Tengjun Biotechnology CEO
CEO
Ms. Qiuping Lu is President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director of the Company. Since June 27, 2012. She has served as the Board Director of Hong Kong Han Fang Zhen Bao Group Holding Company from 2003 to present. Ms. Lu was the Accounting Director of Jiangsu Jiu Jiu Accounting Firm from 1998 to 2003 and was the Accounting Director of Changzhou Nonferrous Metal Factory from 1991 to 1998. Ms. Lu graduated from the Accounting Major of Changzhou Industrial Institute in 1991. since 2016.
Age | 43 |
Tenure | 8 years |
Phone | 919-869-0279 |
Web | http://www.chghus.com |
Tengjun Biotechnology Management Efficiency
The company has return on total asset (ROA) of (257.21) % which means that it has lost $257.21 on every $100 spent on assets. This is way below average. Tengjun Biotechnology's management efficiency ratios could be used to measure how well Tengjun Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 12 records | CEO Age | ||
Trish Donnelly | PVH Corp | 52 | |
Jose Boisjoli | BRP Inc | 66 | |
Michael OSullivan | Burlington Stores | 60 | |
Stefan Larsson | PVH Corp | 49 | |
David Sharp | Rocky Brands | 58 | |
Steve Shiffman | PVH Corp | 59 | |
Daniel Grieder | PVH Corp | 56 | |
Mor Weizer | Playtech plc | 39 | |
Martijn Hagman | PVH Corp | 49 | |
Fred Gehring | PVH Corp | 59 | |
Cheryl Hodges | PVH Corp | 56 | |
Patricia Donnelly | PVH Corp | 55 |
Management Performance
Return On Asset | -257.21 |
Tengjun Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Tengjun Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -257.21 | |||
Current Valuation | 97.32 M | |||
Shares Outstanding | 43.14 M | |||
Shares Owned By Insiders | 64.17 % | |||
Net Income | (49.56 K) | |||
Total Debt | 260.04 K | |||
Current Ratio | 0.03 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (30.14 K) | |||
Earnings Per Share | (0) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tengjun Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tengjun Biotechnology's short interest history, or implied volatility extrapolated from Tengjun Biotechnology options trading.
Pair Trading with Tengjun Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tengjun Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tengjun Biotechnology will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cardinal Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardinal Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardinal Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardinal Health to buy it.
The correlation of Cardinal Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardinal Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardinal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardinal Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Tengjun Biotechnology information on this page should be used as a complementary analysis to other Tengjun Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Tengjun OTC BB Equity
If you are still planning to invest in Tengjun Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tengjun Biotechnology's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |